Abstract
A 62-year-old man was diagnosed with a giant coronary artery aneurysm associated with immunoglobulin G4 (IgG4)-related disease. He had previously undergone two thoracic operations with sternotomies and abdominal aortic aneurysm repair for IgG4-related aortopathy. We opted for hybrid open and endovascular repair to reduce risk and avoid complications of a resternotomy and extracorporeal circulation. This first successful case of hybrid repair of a giant coronary artery aneurysm shows that the procedure is safe and feasible in patients with IgG4-related vasculopathy. It is critical to carefully monitor these patients for the occurrence of new IgG4-related aneurysms and other manifestations of vasculopathy.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Crawley PD, Mahlow WJ, Huntsinger DR, Afiniwala S, Wortham DC. Giant coronary artery aneurysms: review and update. Tex Heart Inst J. 2014;41:603–8.
Lee WC, Fang HY, Fang CY. Hybrid strategy to treat life-threatening giant coronary artery aneurysm with severe in-stent restenosis. Int Heart J. 2017;58:283–5.
Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012;366:539–51.
Kasashima S, Zen Y, Kawashima A, Endo M, Matsumoto Y, Kasashima F. A new clinicopathological entity of IgG4-related inflammatory abdominal aortic aneurysm. J Vasc Surg. 2009;49:1264–71 (discussion 1271).
Matsuyama S, Kishigami T, Sakamoto M. A case of giant right coronary artery aneurysm due to IgG4-related disease. Gen Thorac Cardiovasc Surg. 2020;68:1453–6.
Nikolaidou CN, Vassiliou VS, Watson WD. Coronary artery aneurysms-a truly rare entity or simply unrecognized so far? Oxf Med Case Rep. 2019;29:omz009.
Li D, Wu Q, Sun L, Song Y, Wang W, Pan S, et al. Surgical treatment of giant coronary artery aneurysm. J Thorac Cardiovasc Surg. 2005;130:817–21.
Kim TH, Marfatia R, Lee J, Azrin M. Giant coronary aneurysm management with Viabahn covered stent. Cardiovasc Revasc Med. 2017;18:56–9.
Kawsara A, Núñez Gil IJ, Alqahtani F, Moreland J, Rihal CS, Alkhouli M. Management of coronary artery aneurysms. JACC Cardiovasc Interv. 2018;11:1211–23.
Szalat A, Durst R, Cohen A, Lotan C. Use of polytetrafluoroethylene-covered stent for treatment of coronary artery aneurysm. Catheter Cardiovasc Interv. 2005;66:203–8.
Stone JH, Khosroshahi A, Hilgenberg A, Spooner A, Isselbacher EM, Stone JR. IgG4-related systemic disease and lymphoplasmacytic aortitis. Arthritis Rheum. 2009;60:3139–45.
Sakai K, Watanabe T, Yoshida T. Endovascular treatment of immunoglobulin G4-related inflammatory abdominal aortic aneurysm. J Vasc Surg Cases Innov Tech. 2018;4:189–92.
Kasashima S, Kasashima F, Kawashima A, Endo M, Matsumoto Y, Kawakami K. Clinical outcomes after endovascular repair and open surgery to treat immunoglobulin G4-related and nonrelated inflammatory abdominal aortic aneurysms. J Endovasc Ther. 2017;24:833–45.
Tanigawa J, Daimon M, Takeda Y, Katsumata T, Ishizaka N. Temporal changes in serum IgG4 levels after coronary artery bypass graft surgery. Hum Pathol. 2012;43:2093–5.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
None of the authors have any conflicts of interest to declare.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Kamikawa, Y., Ohashi, T., Tadakoshi, M. et al. Hybrid treatment of a giant coronary artery aneurysm in a patient with immunoglobulin G4-related disease. Gen Thorac Cardiovasc Surg 69, 1347–1351 (2021). https://doi.org/10.1007/s11748-021-01668-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11748-021-01668-4